Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.31 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31741937 | 0.74 | SMN1; SMN2 (0.34) | SMN1; SMN2CYP1A2CYP3A4TSHRHSD17B10 | |
| SCHEMBL4025720 | 0.72 | PIK3CD (0.51) | SMN1; SMN2TSHRL3MBTL1MAPT | |
| SCHEMBL31490429 | 0.71 | L3MBTL1 (0.63) | SMN1; SMN2CYP1A2CYP3A4TSHRHSD17B10 | |
| SCHEMBL243814 | 0.68 | ALDH1A1 (0.53) | SMN1; SMN2CYP1A2HSD17B10MAPT | |
| SCHEMBL6545710 | 0.65 | ADORA3 (0.41) | CYP3A4HSD17B10PIM1PIM3PIM2 | |
| SCHEMBL18282490 | 0.64 | CYP1A2 (0.47) | SMN1; SMN2CYP1A2CYP3A4TSHRHSD17B10 | |
| SCHEMBL28461986 | 0.64 | KMT2A (0.47) | SMN1; SMN2CYP1A2CYP3A4TSHRHSD17B10 | |
| SCHEMBL10200659 | 0.63 | PIM1 (0.45) | SMN1; SMN2PIM1PIM3PIM2 | |
| SCHEMBL244427 | 0.63 | SCD (0.40) | SMN1; SMN2CYP1A2CYP3A4TSHRHSD17B10 | |
| SCHEMBL4023755 | 0.63 | PIK3CD (0.54) | SMN1; SMN2CYP1A2CYP3A4TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4540247-A1 | MULTI-KINASE INHIBITORS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | BIOFRONT LTD (KY) | 2025-04-23 | — | — | EP | disclosed |
| CN-119032093-A | Multi-kinase inhibitors, compositions and methods of use | 百放开曼有限公司 | 2024-11-26 | — | — | CN | disclosed |
| WO-2023246491-A1 | MULTI-KINASE INHIBITORS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | BIOFRONT LTD (KY) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023245329-A1 | MULTI-KINASE INHIBITORS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | BIOFRONT LTD (KY) | 2023-12-28 | — | — | WO | disclosed |